During the past decade, Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012) conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)" are "Gastroesophageal Junction Adenocarcinoma" (2 trials), "COVID-19" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Gastric Cancer" (1 trials) and "Gastric Neoplasms" (1 trials). Many other conditions were trialed in "Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)" in a lesser frequency.

Most popular intervention types in "Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)" are "Drug" (5 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Cisplatin" (2 trials), "Oxaliplatin" (2 trials), "Pembrolizumab" (2 trials) and "5-FU" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012)". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".